MedTrace Logo

Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema

NCT04191629 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2019-12-10

No results posted yet for this study

Summary

Single center, phase 1 study to evaluate the safety and tolerability of EO1404 in subjects with corneal edema secondary to pseudophakic bullous keratopathy or Fuch's endothelial dystrophy.

Conditions

  • Corneal Edema
  • Fuchs Dystrophy
  • Fuchs' Endothelial Dystrophy
  • Pseudophakic Bullous Keratopathy
  • Corneal Endothelial Dystrophy
  • Corneal Transplant Failure

Interventions

COMBINATION_PRODUCT

EO1404

PROCEDURE

Endothelial brushing or Descemet stripping

Sponsors & Collaborators

  • Emmecell

    collaborator INDUSTRY

  • Valeria Sanchez-Huerta

    lead OTHER

Principal Investigators

  • Valeria Sanchez-Huerta, MD · Asociacion Para Evitar la Ceguera

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-04
Primary Completion
2020-12-31
Completion
2021-02-28
FDA Drug
Yes

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04191629 on ClinicalTrials.gov